Molecular testing negative for known actionable mutations
PET CT revealed a liver lesion and adrenal mass
Brain MRI showed no evidence of CNS metastasis
Staging: T2aN3M1b
22C3 antibody testing; PD-L1 TPS, 0%
The patient is started on cisplatin/gemcitabine
Imaging at 3 months shows widespread progression with new and enlarging lesions including a significant increase in her soft tissue and lymph node disease, collapse of her right lower lobe and new liver lesions